The oxygen tolerant radical copolymerization of fluorinated monomers with vinyl ethers at room temperature in the presence of tri-nbutylborane methoxypropylamine (TBBMOPA)/CH 3 COOH system is presented. The combination of commercially available fluoroolefins (FO) [perfluoromethyl vinyl ether (PMVE) and hexafluoropropylene (HFP)] and vinyl ethers (VE) [ethyl vinyl ether (EVE) and 2-(perfluorohexyl)ethyl vinyl ether (FAVE6)] was used for the synthesis of different alternating poly(FOalt-VE) copolymers (up to 43 % yield). The resulting copolymers were characterized by FT-IR, 19 F NMR and 1 H NMR spectroscopy techniques. Thermomechanical properties (T g = -16 to 18 °C) of these polymers were also studied and justified in terms of structure-properties relationships. Their stabilities were investigated as a function of temperature by thermogravimetric analyses. Then, their degradation temperatures related to a weight loss of 5%, (T d5% ) were evaluated as being comprised between 262 and 316 °C while poly(PMVE-alt-EVE) copolymer was characterized by a higher thermostability (T d5% = 382 °C). Their surfaces were found to be hydrophobic, evidenced by water contact angle measured from 95 to 110 °. When soluble in SEC solvent, these fluorinated copolymers reached M n up to 169,200 g mol -1 . Because of these features, such fluorinated copolymers may find applications in paints and coatings or as elastomers.
2-Trifluoromethacrylic acid (MAF) is a peculiar fluorinated functional monomer. Though it is known to polymerise via C=C bond cleavage under anionic initiation, its oxa-Michael addition polymerisation afforded polyesters bearing trifluoromethyl...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.